Eltrog 50MG Tablet (7’s) is a medication that contains Eltrombopag as its active ingredient, with each tablet delivering a dosage of 50 mg. This drug is primarily used to treat conditions related to low platelet counts, such as chronic immune thrombocytopenic purpura (ITP) in adults and children, as well as thrombocytopenia associated with chronic hepatitis C and severe aplastic anemia. Eltrombopag works by stimulating the production of platelets in the bone marrow, thereby increasing platelet counts and reducing the risk of bleeding. The formulation of Eltrog 50MG Tablet is designed for oral administration, making it convenient for patients. It is essential for individuals with specific medical conditions to consult healthcare professionals before starting this medication to ensure its appropriateness for their treatment plan.

Eltrog 25MG Tablet (7’s) is a medication that contains Eltrombopag as its active ingredient, with each tablet delivering a dosage of 25 mg. This drug is primarily used to treat conditions related to low platelet counts, such as chronic immune thrombocytopenic purpura (ITP) in adults and children, as well as thrombocytopenia associated with chronic hepatitis C and severe aplastic anemia. Eltrombopag works by stimulating the production of platelets in the bone marrow, thereby increasing platelet counts and reducing the risk of bleeding. The formulation of Eltrog 25MG Tablet is designed for oral administration, making it convenient for patients. It is essential for individuals with low platelet counts to manage their condition effectively, and Eltrog provides a viable option for improving their health outcomes. The medication is typically prescribed as part of a comprehensive treatment plan, and patients should follow their healthcare provider’s instructions for optimal results.